Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joon Ho Moon

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On <sup>18</sup>F-FDG PET/CT at BaselineHee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, et al.
International Journal of Hematology|January 21, 2021
Prognostic impact of <sup>18</sup>F-FDG PET/CT in patients with multiple myeloma presenting with renal impairmentSeo-Yeon Ahn, Hwa Kyung Park, Joon Ho Moon, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
The Korean Journal of Internal Medicine|January 25, 2023
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myelomaHee Jeong Cho, Jae-Cheol Jo, Yoo Jin Lee, et al.
Acta Haematologica|June 13, 2015
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic SyndromeJae-Sook Ahn, Yeo-Kyeoung Kim, Yoo Hong Min, et al.
Ophthalmology Science|May 27, 2026
Marker-Free, Automated Eyelid Assessment in Thyroid Eye Disease Using Artificial Intelligence: A Multicenter Validation StudyJae Hoon Moon, Jongchan Kim, Joonhyeon Park, et al.
Cancer Research and Treatment|January 26, 2023
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid LeukemiaSeo-Yeon Ahn, TaeHyung Kim, Mihee Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2015
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell TransplantationJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
American Journal of Hematology|August 14, 2012
A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemiaJungwon Huh, Hee-Je Kim, Chul Won Jung, et al.
The Korean Journal of Internal Medicine|January 30, 2024
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort studyHo-Young Yhim, Yong Park, Jeong-A Kim, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Clinical Lymphoma, Myeloma & Leukemia|October 2, 2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On <sup>18</sup>F-FDG PET/CT at BaselineHee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, et al.
International Journal of Hematology|January 21, 2021
Prognostic impact of <sup>18</sup>F-FDG PET/CT in patients with multiple myeloma presenting with renal impairmentSeo-Yeon Ahn, Hwa Kyung Park, Joon Ho Moon, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
The Korean Journal of Internal Medicine|January 25, 2023
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myelomaHee Jeong Cho, Jae-Cheol Jo, Yoo Jin Lee, et al.
Acta Haematologica|June 13, 2015
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic SyndromeJae-Sook Ahn, Yeo-Kyeoung Kim, Yoo Hong Min, et al.
Ophthalmology Science|May 27, 2026
Marker-Free, Automated Eyelid Assessment in Thyroid Eye Disease Using Artificial Intelligence: A Multicenter Validation StudyJae Hoon Moon, Jongchan Kim, Joonhyeon Park, et al.
Cancer Research and Treatment|January 26, 2023
Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid LeukemiaSeo-Yeon Ahn, TaeHyung Kim, Mihee Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2015
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell TransplantationJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
American Journal of Hematology|August 14, 2012
A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemiaJungwon Huh, Hee-Je Kim, Chul Won Jung, et al.
The Korean Journal of Internal Medicine|January 30, 2024
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort studyHo-Young Yhim, Yong Park, Jeong-A Kim, et al.
Pageof 28